Skip to main content

Table 3 Effects of different treatment options on hospital and Intensive care unit stay of patients, modeled with univariate and multivariate linear regression

From: Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand?

Drugs

Intensive Care Unit Stay

Hospital Stay

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

Coefficient (se*)

P value

Coefficient (se)

P value

Coefficient (se)

P value

Coefficient (se)

P value

Hydroxychloroquine

2.456 (1.44)

0.09

1.636 (1.02)

0.12

1.55 (2.21)

0.485

Interferon

3.97 (2.23)

0.08

0.759 (3.05)

0.80

1.39 (3.41)

0.685

Lopinavir/Ritonavir

7.83 (1.229)

< 0.001

5.309 (1.23)

< 0.001

3.27 (2.31)

0.161

3.44 (3.06)

0.27

Remdesivir

0.91

0.03

0.721(0.21)

0.03

− 0.77 (2.14)

0.01

0.10 (2.00)

< 0.001

High dose methylprednisolone or dexamethasone

0.103 (1.56)

0.94

1.572 (2.40)

0.514

Tocilizumab

0.71

0.02

0.66(0.10)

< 0.001

0.90 (1.10)

0.04

0.22

0.04

  1. *Standard error